"The June 17 meeting, between officials at the Environmental Protection Agency (EPA) and Bayer CEO Bill Anderson and two other top Bayer executives, came as Germany-based Bayer was working to quash costly U.S. litigation brought by tens of thousands of people who allege they developed cancer from their use of the company's glyphosate-based herbicides, such as Roundup."
"One of Bayer's stated key strategies to try to end the litigation, which has so far cost Bayer billions of dollars in settlements and jury verdict awards, is getting the Supreme Court to agree with Bayer's argument that if the EPA does not require a cancer warning on its glyphosate products, the company cannot be held liable for failing to warn of a cancer risk."
"While one appellate court has sided with Bayer, multiple other courts have rejected that preemption argument, as did the U.S. Solicitor General under the Biden administration. In contrast, the Trump administration has acted to defend and promote Bayer's position and its glyphosate herbicides."
Top U.S. regulators at the EPA met with Bayer CEO Bill Anderson in June 2023 to discuss litigation issues surrounding the company's glyphosate-based herbicides like Roundup. Tens of thousands of people have sued Bayer, claiming they developed cancer from using these products and that the company failed to warn of cancer risks. Bayer's primary legal strategy involves convincing the Supreme Court that if the EPA does not require cancer warnings, the company cannot be held liable for failing to warn users. While one appellate court supported Bayer's preemption argument, multiple other courts rejected it, as did the Biden administration's Solicitor General. The Trump administration subsequently took actions to defend and promote Bayer's position and glyphosate products.
#bayer-glyphosate-litigation #epa-regulatory-meeting #trump-administration-support #roundup-cancer-lawsuits #supreme-court-preemption-argument
Read at Truthout
Unable to calculate read time
Collection
[
|
...
]